Authors: Szumacher, E Wighton, A Franssen, E Chow, E Tsao, M Ackerman, I Andersson, L Kim, J Wojcicka, A Ung, Y Sixel, K Hayter, C

Citation: E. Szumacher et al., Phase II study assessing the effectiveness of biafine cream as a prophylactic agent for radiation-induced acute skin toxicity to the breast in women undergoing radiotherapy with concomitant CMF chemotherapy, INT J RAD O, 51(1), 2001, pp. 81-86

Authors: Bordeleau, L Rakovitch, E Naimark, DM Pritchard, KI Ackerman, I Sawka, GA

Citation: L. Bordeleau et al., A comparison of four treatment strategies for ductal carcinoma in situ using decision analysis, CANCER, 92(1), 2001, pp. 23-29

Authors: Goshen, R Chu, W Elit, L Pal, T Hakimi, J Ackerman, I Fyles, A Mitchell, M Narod, SA

Citation: R. Goshen et al., Is uterine papillary serous adenocarcinoma a manifestation of the hereditary breast-ovarian cancer syndrome?, GYNECOL ONC, 79(3), 2000, pp. 477-481

Authors: Yamada, Y Ackerman, I

Citation: Y. Yamada et I. Ackerman, Regarding Yamada et al. IJROBP 44 : 99-104;1999 - In response to Dr. Magee, INT J RAD O, 45(3), 1999, pp. 827-827

Authors: Yamada, Y Ackerman, I Franssen, E MacKenzie, RG Thomas, G

Citation: Y. Yamada et al., Does the dose fractionation schedule influence local control of adjuvant radiotherapy for early stage breast cancer?, INT J RAD O, 44(1), 1999, pp. 99-104